D. Intravenous procainamide
Why this is correct
Pre-excited atrial fibrillation can conduct extremely rapidly down an accessory pathway and degenerate into ventricular fibrillation. In a hemodynamically stable patient, IV procainamide or ibutilide is a guideline-supported pharmacologic strategy. AV-nodal blocking agents, including verapamil, diltiazem, beta blockers, digoxin, and adenosine, are contraindicated because they may favor accessory-pathway conduction. Hemodynamic instability calls for immediate synchronized electrical cardioversion.
Why each option is correct or incorrect
Diltiazem blocks AV nodal conduction and may worsen accessory-pathway-mediated ventricular response.
Adenosine is an AV nodal blocker and is unsafe in pre-excited AF.
Digoxin can favor hazardous accessory-pathway conduction and is contraindicated.
Correct: procainamide can slow conduction through the accessory pathway in stable pre-excited AF.
High-yield notes
- Irregular, very rapid wide-complex rhythm with variable morphology may indicate pre-excited AF.
- Stable pre-excited AF: procainamide or ibutilide may be used.
- Unstable pre-excited AF: immediate synchronized electrical cardioversion.
Never treat pre-excited AF with AV-nodal blockers.
Adenosine may be used for selected regular AVRT rhythms, but not irregular pre-excited AF.